glipizide has been researched along with Alloxan Diabetes in 14 studies
Glipizide: An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.
glipizide : An N-sulfonylurea that is glyburide in which the (5-chloro-2-methoxybenzoyl group is replaced by a (5-methylpyrazin-2-yl)carbonyl group. An oral hypoglycemic agent, it is used in the treatment of type 2 diabetes mellitus.
| Excerpt | Relevance | Reference |
|---|---|---|
| ") ethanolic extract (APE) and andrographolide (AND) (a potent CYP2C9 inducer/inhibitor) can alter the pharmacokinetic parameters of glipizide (GLZ)." | 1.72 | Pharmacokinetic Herb-Drug Interactions of Glipizide with ( Amalia Prihati, D; Lukitaningsih, E; Nugroho, AE; Nurrochmad, A; Puspitasari, I; Sundhani, E, 2022) |
| " AZI (500 mg/kg) pretreatment significantly decreased AUC and increased Tmax to 8 h." | 1.51 | Effect of Aqueous Extract of Azadirachta indica Leaves on Pharmacokineics and Pharmacodynamics of Glipizide. ( Ali, M; Chaudhari, S; Zambad, S, 2019) |
| " Aqueous extract of Annona squamosa was administered orally at 350 mg/kg body weight alone and in combination with reduced and reducing dose combinations of Glipizide." | 1.39 | Polypharmacy (herbal and synthetic drug combination): a novel approach in the treatment of type-2 diabetes and its complications in rats. ( Afzal, M; Ahamd, I; Ahmad, S; Ahmed, Z; Ali, B; Anwar, F; Kaur, R; Kazmi, I, 2013) |
| " Oral therapy with glipizide comprises problems of bioavailability fluctuations and may be associated with severe hypoglycaemia and gastric disturbances." | 1.33 | A transdermal delivery system for glipizide. ( Ammar, HO; El-Nahhas, SA; Elmotasem, H; Ghorab, M; Salama, HA, 2006) |
| "Glipizide therapy also was ineffective in improving plasma insulin levels, which were significantly depressed in the diabetic group." | 1.29 | Effects of chronic glipizide treatment on the NIDD heart. ( Schaffer, SW; Warner, BA; Wilson, GL, 1993) |
| "Glipizide-treated mice improved their OGTT." | 1.28 | Diabetic microangiopathy in KK mice. VI. Effect of glycemic control on renal glycoprotein metabolism and established glomerulosclerosis. ( Camerini-Davalos, RA; Khan, MY; Reddi, AS; Reddy, PR; Velasco, CA, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Sundhani, E | 1 |
| Nugroho, AE | 1 |
| Nurrochmad, A | 1 |
| Puspitasari, I | 1 |
| Amalia Prihati, D | 1 |
| Lukitaningsih, E | 1 |
| Ray, S | 1 |
| Bera, M | 1 |
| Bhattacharyya, UK | 1 |
| Das, S | 1 |
| Seth, S | 1 |
| Pal, PK | 1 |
| Aziz, A | 1 |
| Chaudhari, S | 1 |
| Zambad, S | 1 |
| Ali, M | 1 |
| Whittam, AJ | 1 |
| Maan, ZN | 1 |
| Duscher, D | 1 |
| Barrera, JA | 1 |
| Hu, MS | 1 |
| Fischer, LH | 1 |
| Khong, S | 1 |
| Kwon, SH | 1 |
| Wong, VW | 1 |
| Walmsley, GG | 1 |
| Giacco, F | 1 |
| Januszyk, M | 1 |
| Brownlee, M | 1 |
| Longaker, MT | 1 |
| Gurtner, GC | 1 |
| Mu, J | 1 |
| Petrov, A | 1 |
| Eiermann, GJ | 1 |
| Woods, J | 1 |
| Zhou, YP | 1 |
| Li, Z | 1 |
| Zycband, E | 1 |
| Feng, Y | 1 |
| Zhu, L | 1 |
| Roy, RS | 1 |
| Howard, AD | 1 |
| Li, C | 1 |
| Thornberry, NA | 1 |
| Zhang, BB | 1 |
| Kumar, S | 1 |
| Kunaparaju, N | 1 |
| Zito, SW | 1 |
| Barletta, MA | 1 |
| Kaur, R | 1 |
| Afzal, M | 1 |
| Kazmi, I | 1 |
| Ahamd, I | 1 |
| Ahmed, Z | 1 |
| Ali, B | 1 |
| Ahmad, S | 1 |
| Anwar, F | 1 |
| Srinivasan, K | 1 |
| Viswanad, B | 1 |
| Asrat, L | 1 |
| Kaul, CL | 1 |
| Ramarao, P | 1 |
| Ammar, HO | 1 |
| Salama, HA | 1 |
| Ghorab, M | 1 |
| El-Nahhas, SA | 1 |
| Elmotasem, H | 1 |
| Li, W | 1 |
| Dai, RJ | 1 |
| Yu, YH | 1 |
| Li, L | 1 |
| Wu, CM | 1 |
| Luan, WW | 1 |
| Meng, WW | 1 |
| Zhang, XS | 1 |
| Deng, YL | 1 |
| Schaffer, SW | 1 |
| Warner, BA | 1 |
| Wilson, GL | 1 |
| Tüzün, S | 1 |
| Girgin, FK | 1 |
| Sözmen, EY | 1 |
| Menteş, G | 1 |
| Ersöz, B | 1 |
| Reddi, AS | 2 |
| Velasco, CA | 2 |
| Reddy, PR | 1 |
| Khan, MY | 2 |
| Camerini-Davalos, RA | 2 |
| Bloodworth, JM | 1 |
14 other studies available for glipizide and Alloxan Diabetes
| Article | Year |
|---|---|
Pharmacokinetic Herb-Drug Interactions of Glipizide with
Topics: Andrographis; Andrographis paniculata; Animals; Chromatography, High Pressure Liquid; Cytochrome P-4 | 2022 |
pH Sensitive Interpenetrating Network Bio Containers of Gum Ghatti for Sustained Release of Glipizide.
Topics: Animals; Blood Glucose; Cell Survival; Cells, Cultured; Delayed-Action Preparations; Diabetes Mellit | 2019 |
Effect of Aqueous Extract of Azadirachta indica Leaves on Pharmacokineics and Pharmacodynamics of Glipizide.
Topics: Animals; Area Under Curve; Azadirachta; Blood Glucose; Cytochrome P-450 CYP3A; Diabetes Mellitus, Ex | 2019 |
Small molecule inhibition of dipeptidyl peptidase-4 enhances bone marrow progenitor cell function and angiogenesis in diabetic wounds.
Topics: Animals; Chemokine CXCL12; Diabetes Mellitus, Experimental; Dipeptidyl Peptidase 4; Dipeptidyl-Pepti | 2019 |
Inhibition of DPP-4 with sitagliptin improves glycemic control and restores islet cell mass and function in a rodent model of type 2 diabetes.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dietary Fats; Di | 2009 |
Effect of Wrightia tinctoria and Parthenocissus quinquefolia on blood glucose and insulin levels in the Zucker diabetic rat model.
Topics: Animals; Apocynaceae; Diabetes Mellitus, Experimental; Enzyme-Linked Immunosorbent Assay; Female; Gl | 2011 |
Polypharmacy (herbal and synthetic drug combination): a novel approach in the treatment of type-2 diabetes and its complications in rats.
Topics: Administration, Oral; Animals; Annona; Behavior, Animal; Blood Glucose; Body Weight; Catalase; Diabe | 2013 |
Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening.
Topics: Animals; Blood Glucose; Cholesterol; Diabetes Mellitus, Experimental; Dietary Fats; Glipizide; Gluco | 2005 |
A transdermal delivery system for glipizide.
Topics: Acrylic Resins; Adjuvants, Pharmaceutic; Administration, Cutaneous; Animals; Biological Availability | 2006 |
Antihyperglycemic effect of Cephalotaxus sinensis leaves and GLUT-4 translocation facilitating activity of its flavonoid constituents.
Topics: Adipocytes; Animals; Blood Glucose; Blotting, Western; Carboxymethylcellulose Sodium; Cell Membrane; | 2007 |
Effects of chronic glipizide treatment on the NIDD heart.
Topics: Animals; Animals, Newborn; Blood Glucose; Cardiac Output, Low; Diabetes Mellitus, Experimental; Diab | 1993 |
Antioxidant status in experimental type 2 diabetes mellitus: effects of glibenclamide and glipizide on various rat tissues.
Topics: Animals; Antioxidants; Brain; Catalase; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; | 1999 |
Diabetic microangiopathy in KK mice. VI. Effect of glycemic control on renal glycoprotein metabolism and established glomerulosclerosis.
Topics: Acetylglucosaminidase; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Angiopathie | 1990 |
Kidney disease in KK mice: effect of glipizide.
Topics: Animals; Basement Membrane; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; | 1988 |